Have We Got Thy3 Wrong in the UK? A Four-Year Single-Site Analysis of Malignancy Rates in Thy3 Nodules
- PMID: 35003965
- PMCID: PMC8723696
- DOI: 10.7759/cureus.20125
Have We Got Thy3 Wrong in the UK? A Four-Year Single-Site Analysis of Malignancy Rates in Thy3 Nodules
Abstract
Introduction Thyroid nodules routinely undergo ultrasound-guided fine-needle aspiration (FNA), as recommended by the National Institute for Health and Care Excellence (NICE) and the British Thyroid Association (BTA). The cytology results are classified using the "Thy" system from Thy1 to Thy5. Intermediate Thy3 FNA results are challenging, as this suggests malignancy is possible, but the relatively low rates of malignancy can make decision-making difficult. Thy3 is further subdivided into Thy3a and Thy3f. BTA recommends further ultrasound with or without FNA cytology for Thy3a nodules and hemithyroidectomy for Th3yf nodules based on a published positive predictive value (PPV) for malignancy of 17% for Thy3a and up to 40% for Thy3f results. We aim to compare the actual malignancy rates of Thy3 nodules in our unit to these figures. Methods A retrospective study was performed looking at the histologically confirmed malignancy rates in Thy3a and Thy3f cytology over four years between January 2016 and December 2019. Results There were 162 separate Thy3 nodules in 156 patients included in this study, of which 60 were classified as Thy3a and 102 as Thy3f. 10% of patients with Thy3a nodules underwent repeat cytology. The histologically confirmed malignancy rate was 33% in Thy3a and 11% in Thy3f lesions. Discussion We found the rates of histologically confirmed malignancy are reversed compared to the published PPVs with a higher rate in Thy3a nodules and a lower rate in Thy3f. This suggests that the surgical decision-making and patient counselling may be based on flawed data in our unit and possibly throughout the UK, making a wider study involving multiple centers desirable.
Keywords: : thyroid nodule; diagnostic test accuracy; fine needle aspiration cytology (fnac); thyroid cancer; thyroid cytology; thyroid histology.
Copyright © 2021, Chandrasekar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Malignancy rates and initial management of Thy3 thyroid nodules in a district general hospital: The 'Reading' experience.Endocrinol Diabetes Metab. 2021 Feb 24;4(3):e00243. doi: 10.1002/edm2.243. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277968 Free PMC article.
-
Thyroid cytology-histology correlation using the RCPath terminology for thyroid cytology reporting.J Clin Pathol. 2017 Aug;70(8):648-655. doi: 10.1136/jclinpath-2016-204022. Epub 2017 Jan 12. J Clin Pathol. 2017. PMID: 28082414
-
Thy 3F and 3a malignancy rate, a multisite regional retrospective case series.Ann R Coll Surg Engl. 2018 Sep;100(7):545-550. doi: 10.1308/rcsann.2018.0103. Epub 2018 Jul 3. Ann R Coll Surg Engl. 2018. PMID: 29968505 Free PMC article.
-
Risk of malignancy in the various categories of the UK Royal College of Pathologists Thy terminology for thyroid FNA cytology: A systematic review and meta-analysis.Cancer Cytopathol. 2020 Jan;128(1):36-42. doi: 10.1002/cncy.22201. Epub 2019 Nov 13. Cancer Cytopathol. 2020. PMID: 31722134
-
Thy3 cytology: what to do next?Ann R Coll Surg Engl. 2011 Apr;93(3):225-8. doi: 10.1308/147870811X565232. Ann R Coll Surg Engl. 2011. PMID: 21477436 Free PMC article. Review.
Cited by
-
Indeterminate thyroid nodules (Thy3): malignancy rate and characteristics in a study of 118 patients.Ann R Coll Surg Engl. 2023 Jul;105(6):568-571. doi: 10.1308/rcsann.2022.0163. Epub 2023 Mar 16. Ann R Coll Surg Engl. 2023. PMID: 36927065 Free PMC article.
References
-
- Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Cooper DS, Doherty GM, Haugen BR, et al. Thyroid. 2009;19:1167–1214. - PubMed
-
- Thyroid disease assessment and management: summary of NICE guidance. Vasileiou M, Gilbert J, Fishburn S, Boelaert K. BMJ. 2020;368:0. - PubMed
-
- Cancer Research UK: Thyroid cancer. [ Nov; 2021 ];https://www.cancerresearchuk.org/about-cancer/thyroid-cancer 2021
-
- The Royal College of Pathologists: Guidance on the reporting of thyroid cytology specimens. [ Nov; 2021 ];Cross Cross, P. Chandra, A. Giles T. Johnson S. Kocjan G. Poller D ST. https://www.rcpath.org/uploads/assets/7d693ce4-0091-4621-97f79e2a0d1034d... 2016
-
- Guidelines for the management of thyroid cancer. Perros P, Boelaert K, Colley S, et al. Clin Endocrinol (Oxf) 2014;81 Suppl 1:1–122. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous